Mary K. Moreland, EXECUTIVE VICE PRESIDENT at ABBOTT LABORATORIES (ABT), sold 1,193 shares at $119.31 ($140K) on 2021-02-22, disclosed to the SEC on 2022-02-23.
Scheduled sale ($140k) by EXECUTIVE VICE PRESIDENT under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $119.31 | 400 | $48K | 34.0% |
| 2 | $116.79 | 793 | $93K | 66.0% |
| Total | $117.63 avg | 1,193 | $140K | 100% |
| Filing → |
| ABT | SELL | 2024-03-04 | $80K | — | Filing → |
| ABT | SELL | 2023-03-02 | $145K | — | Filing → |
| ABT | SELL | 2021-02-23 | $49K | — | Filing → |